MX360299B - Circulacion de componentes durante la homogenizacion de emulsiones. - Google Patents

Circulacion de componentes durante la homogenizacion de emulsiones.

Info

Publication number
MX360299B
MX360299B MX2014014450A MX2014014450A MX360299B MX 360299 B MX360299 B MX 360299B MX 2014014450 A MX2014014450 A MX 2014014450A MX 2014014450 A MX2014014450 A MX 2014014450A MX 360299 B MX360299 B MX 360299B
Authority
MX
Mexico
Prior art keywords
circulation
emulsions
components during
during homogenization
container
Prior art date
Application number
MX2014014450A
Other languages
English (en)
Inventor
Rueckl Harald
Scheffczik Hanno
Santry Barbara
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43923723&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX360299(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX360299B publication Critical patent/MX360299B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40—Mixing liquids with liquids; Emulsifying
    • B01F23/41—Emulsifying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/40—Static mixers
    • B01F25/44—Mixers in which the components are pressed through slits
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F27/00—Mixers with rotary stirring devices in fixed receptacles; Kneaders
    • B01F27/27—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices
    • B01F27/271—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator
    • B01F27/2711—Mixers with stator-rotor systems, e.g. with intermeshing teeth or cylinders or having orifices with means for moving the materials to be mixed radially between the surfaces of the rotor and the stator provided with intermeshing elements
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00—Other mixers; Mixing plants; Combinations of mixers
    • B01F33/80—Mixing plants; Combinations of mixers
    • B01F33/81—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles
    • B01F33/811—Combinations of similar mixers, e.g. with rotary stirring devices in two or more receptacles in two or more consecutive, i.e. successive, mixing receptacles or being consecutively arranged
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Edible Oils And Fats (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Liquid Carbonaceous Fuels (AREA)
  • Display Devices Of Pinball Game Machines (AREA)

Abstract

La presente invención se refiere a un método para una fabricación a gran escala de una emulsión de aceite de agua uniforme, el método que comprende las etapas de: proporcionar una primera emulsión pasar la primera emulsión a través de un dispositivo al menos dos veces, en donde el dispositivo funciona a alta presión y alta velocidad suficiente para reducir el tamaño promedio de las gotitas de aceite en la primera emulsión con el fin de formar una segunda emulsión; y, filtrar la segunda emulsión con una membrana hidrófila asimétrica a fin de formar una emulsión de aceite en agua uniforme, caracterizado porque el tamaño promedio de gotita de aceite es de 220 nm o menos y el número de gotitas de aceite que tienen un tamaño > 1.2 µm es 5 x 108/ml o menos, y en donde la emulsión de aceite en agua uniforme tiene un volumen mayor que o igual a 50 litros.
MX2014014450A 2009-12-03 2010-12-03 Circulacion de componentes durante la homogenizacion de emulsiones. MX360299B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28351809P 2009-12-03 2009-12-03
PCT/IB2010/003394 WO2011067673A2 (en) 2009-12-03 2010-12-03 Circulation of components during homogenization of emulsions

Publications (1)

Publication Number Publication Date
MX360299B true MX360299B (es) 2018-10-29

Family

ID=43923723

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2014014450A MX360299B (es) 2009-12-03 2010-12-03 Circulacion de componentes durante la homogenizacion de emulsiones.
MX2012006216A MX2012006216A (es) 2009-12-03 2010-12-03 Circulacion de componentes durante la homogenizacion de emulsiones.
MX2014014449A MX344381B (es) 2009-12-03 2010-12-03 Circulacion de componentes durante la homogenizacion de emulsiones.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2012006216A MX2012006216A (es) 2009-12-03 2010-12-03 Circulacion de componentes durante la homogenizacion de emulsiones.
MX2014014449A MX344381B (es) 2009-12-03 2010-12-03 Circulacion de componentes durante la homogenizacion de emulsiones.

Country Status (24)

Country Link
US (6) US8895629B2 (es)
EP (4) EP2506834B1 (es)
JP (2) JP5820390B2 (es)
KR (1) KR101523215B1 (es)
CN (2) CN105055311A (es)
AU (1) AU2010325752B2 (es)
BR (1) BR112012013427B8 (es)
CA (1) CA2782511C (es)
DK (2) DK2356983T3 (es)
EA (1) EA024770B1 (es)
ES (3) ES2975170T3 (es)
FI (1) FI2638895T3 (es)
HR (1) HRP20130398T1 (es)
HU (1) HUE066873T2 (es)
IL (1) IL219984B (es)
MX (3) MX360299B (es)
NZ (1) NZ600323A (es)
PL (1) PL2356983T3 (es)
PT (1) PT2356983E (es)
RS (1) RS52748B (es)
SG (2) SG181096A1 (es)
SI (2) SI2356983T1 (es)
SM (1) SMT201300044B (es)
WO (1) WO2011067673A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11707520B2 (en) 2005-11-03 2023-07-25 Seqirus UK Limited Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
PL1945252T3 (pl) * 2005-11-04 2013-11-29 Seqirus Uk Ltd Szczepionki zawierające oczyszczone antygeny powierzchniowe otrzymane z wirusów grypy hodowanych w hodowli komórkowej i skwalen jako adiuwant
EP2396032B1 (en) 2009-02-10 2016-09-28 Seqirus UK Limited Influenza vaccines with reduced amounts of squalene
EP2506832B1 (en) 2009-12-03 2014-02-26 Novartis AG Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506834B1 (en) 2009-12-03 2016-03-02 Novartis AG Circulation of components during homogenization and microfluidization of emulsions
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
CN105125488A (zh) 2010-05-12 2015-12-09 诺华股份有限公司 制备鲨烯的改良方法
AU2013229432A1 (en) 2012-03-08 2014-10-16 Novartis Ag Adjuvanted formulations of booster vaccines
BR112015005056A2 (pt) 2012-09-06 2017-11-21 Novartis Ag vacinas de combinação com sorogrupo b meningococcus e d/t/p
JP6440619B2 (ja) 2012-10-12 2018-12-19 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 混合ワクチン用の架橋されていない無細胞百日咳抗原
BR112015014250A2 (pt) 2012-12-18 2017-07-11 Glaxosmithkline Biologicals Sa método para imunizar um bebê, vacina de combinação e, kit
RU2550253C2 (ru) * 2013-06-25 2015-05-10 Татьяна Владимировна Шленская Устройство для получения гомогенного молочного продукта и способ гидратации полярных молекул аминокислот молочных белков в процессе приготовления гомогенного молочного продукта
US9127542B2 (en) 2014-01-28 2015-09-08 Lawrence O. Price Subterranean well treatment process
US20170304429A1 (en) 2014-09-26 2017-10-26 Seqirus UK Limited Vaccination of immunocompromised subjects
HUE060456T2 (hu) 2014-09-26 2023-03-28 Seqirus Uk Ltd Immunkompromittált alanyok oltása
US10238739B2 (en) 2014-12-02 2019-03-26 Novartis Ag Manufacture of surfactant-containing compositions with enhanced stability
WO2017214497A1 (en) 2016-06-10 2017-12-14 Clarity Cosmetics Inc. Non-comedogenic hair and scalp care formulations and method for use
IT201800007790A1 (it) * 2018-08-02 2020-02-02 Gea Mech Equipment Italia Spa Omogeneizzatore ad alta pressione
EP3714968A1 (en) * 2019-03-29 2020-09-30 Sulzer Mixpac AG Dynamic mixer, dispensing assembly and method of dispensing multi- component material from a cartridge
CN111999489B (zh) * 2020-09-21 2024-08-09 上海科华生物工程股份有限公司 用于连续生产胶乳免疫比浊法的过滤分散设备和方法
WO2022112191A1 (en) * 2020-11-25 2022-06-02 Univerza V Ljubljani Liquid decontamination system comprising a cavitation device and method of decontamination of a liquid
CN116549387A (zh) * 2022-01-29 2023-08-08 江苏瑞科生物技术股份有限公司 乳剂制备方法

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1876979U (de) 1963-06-14 1963-08-01 Rehau Plastiks Sickerleitungsrohr.
CA951238A (en) 1970-06-10 1974-07-16 Ralph R. Calaceto Abrasion resistant venturi scrubbers
US4060082A (en) 1976-08-16 1977-11-29 Mpl, Inc. Dual-ingredient medication dispenser
US4340482A (en) 1978-02-21 1982-07-20 Millipore Corporation Process for grafting amino acid molecules onto preformed polymer surfaces and products prepared thereby
US4673504A (en) 1980-10-27 1987-06-16 Cuno Inc. Charge modified microporous membrane
US4473474A (en) 1980-10-27 1984-09-25 Amf Inc. Charge modified microporous membrane, process for charge modifying said membrane and process for filtration of fluid
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4432875A (en) 1981-05-29 1984-02-21 Brunswick Corporation Semi-permeable membranes and processes for making the same
US4473475A (en) 1981-05-29 1984-09-25 Amf Inc. Charge modified microporous membrane, process for charge modifying said membrane, and process for filtration of fluids
US4413074A (en) 1982-01-25 1983-11-01 Brunswick Corporation Hydrophilic surfaces and process for making the same
NZ209308A (en) 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US4705753A (en) 1984-06-08 1987-11-10 Gregor Harry P Biologically active acrylonitrile-based copolymeric membrane
US4618533A (en) 1984-11-30 1986-10-21 Millipore Corporation Porous membrane having hydrophilic surface and process
US4794002A (en) 1985-11-01 1988-12-27 Monsanto Company Modified polymeric surfaces and process for preparing same
US4964990A (en) 1987-05-20 1990-10-23 Gelman Sciences, Inc. Filtration membranes and method of making the same
US4943374A (en) 1988-04-21 1990-07-24 Gessner & Co., Gmbh Use of a microporous membrane constructed of polyether sulfon and hydrophilization agent for the filtration of beer
DE68928907T2 (de) 1988-10-17 1999-09-16 Hemasure,Inc. Verfahren zur kovalenten oberflächen-modifikation hydrophober polymere und erzeugnisse daraus
JPH0832638B2 (ja) 1989-05-25 1996-03-29 カイロン コーポレイション サブミクロン油滴乳剤を含んで成るアジュバント製剤
EP0538437B1 (en) * 1991-05-08 1999-08-04 SCHWEIZ. SERUM- & IMPFINSTITUT BERN Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
JPH0614756Y2 (ja) 1991-06-26 1994-04-20 株式会社アルテ 組み立て式の２室式容器兼用注射器
US5178765A (en) 1991-09-18 1993-01-12 Gelman Sciences Inc. Hydrophilic membranes prepared from polyethersulfone/poly-2-oxazoline/polyvinylpyrrolidone blend
AU680813B2 (en) 1992-08-28 1997-08-14 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
US5531893A (en) 1993-02-12 1996-07-02 Gelman Sciences Inc. Inter-penetrating network charge modified microporous membrane
US5277812A (en) 1993-02-12 1994-01-11 Gelman Sciences Inc. Inter-penetrating network charge modified microporous membrane
US6645463B1 (en) 1994-05-16 2003-11-11 The Board Of Regents Of The University Of Michigan Blood-pool selective carrier for lipophilic imaging agents
DE69528062T2 (de) 1994-06-20 2003-04-30 Nippon Shinyaku Co., Ltd. Verfahren zum herstellen von emulsionen aus einem emulgator
US5487965A (en) 1994-09-06 1996-01-30 Xerox Corporation Processes for the preparation of developer compositions
US5496284A (en) 1994-09-27 1996-03-05 Waldenburg; Ottfried Dual-chamber syringe & method
US5510118A (en) * 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
DE19542499A1 (de) 1995-11-15 1997-05-22 Bayer Ag Verfahren und Vorrichtung zur Herstellung einer parenteralen Arzneistoffzubereitung
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
AU3186297A (en) 1996-07-05 1998-02-02 Debiotech S.A. Dual-chamber syringe for mixing two substances prior to injection
US6168718B1 (en) 1996-11-08 2001-01-02 Pall Corporation Method for purifying blood plasma and apparatus suitable therefor
DE69729741T2 (de) 1996-11-12 2005-07-07 Whatman Inc., Cleveland Hydrophile polymermembran für phasenumkehr
WO1999017820A1 (en) 1997-10-03 1999-04-15 Texas Pharmaceuticals, Inc. Improved dual chamber syringe apparatus
US5971953A (en) 1998-01-09 1999-10-26 Bachynsky; Nicholas Dual chamber syringe apparatus
US6039872A (en) 1997-10-27 2000-03-21 Pall Corporation Hydrophilic membrane
WO1999050189A1 (en) 1998-03-30 1999-10-07 Ebara Corporation Method and device for treating manganese-containing water
GB9808689D0 (en) 1998-04-23 1998-06-24 Kalsep Ltd Improved membrane
JP3995830B2 (ja) 1999-01-13 2007-10-24 富士フイルム株式会社 熱現像画像記録材料
US6193077B1 (en) 1999-02-08 2001-02-27 Osmonics, Inc. Non-cracking hydrophilic polyethersulfone membranes
CA2363141C (en) 1999-02-26 2010-04-06 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
KR100310234B1 (ko) 1999-08-20 2001-11-14 안복현 반도체 소자 ｃｍｐ용 금속산화물 슬러리의 제조방법
GB9923176D0 (en) 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
DE10059430A1 (de) 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
TWI228420B (en) 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
US20060148776A1 (en) 2003-03-13 2006-07-06 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
US20040185068A1 (en) 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
PL1613346T3 (pl) 2003-04-04 2013-03-29 Zoetis Services Llc Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek
EP1633322A2 (en) 2003-06-04 2006-03-15 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
US20050208083A1 (en) * 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
BRPI0509184A (pt) 2004-03-23 2007-09-18 Novartis Ag composições farmacêuticas
EP1728528B1 (en) 2004-03-23 2013-06-19 Nipro Corporation Pre-filled syringe
GB0406515D0 (en) * 2004-03-23 2004-04-28 Novartis Ag Organic compounds
WO2005097181A1 (en) 2004-04-05 2005-10-20 Pfizer Products Inc. Microfluidized oil-in-water emulsions and vaccine compositions
GB0411411D0 (en) * 2004-05-21 2004-06-23 Glaxosmithkline Biolog Sa Vaccines
DE102004031550A1 (de) 2004-06-29 2006-02-02 Cognis Ip Management Gmbh Hochkonzentrierte, selbstemulgierende Emulsionsgrundlagen zur Herstellung von Öl in Wasser Emulsionen
GB0416120D0 (en) 2004-07-19 2004-08-18 Health Prot Agency Stable compositions containing OMV's
AU2005295777A1 (en) 2004-10-13 2006-04-27 3M Innovative Properties Company Method for preparing hydrophilic polyethersulfone membrane
TW200611880A (en) 2004-10-14 2006-04-16 Bi-Chang Li The microprocessor unit of bio-sludge-hydrolyzing equipment
EP1827373B1 (en) 2004-11-09 2008-12-03 Novagali Pharma SA Ophthalmic emulsions containing prostaglandins
GB0427568D0 (en) 2004-12-16 2005-01-19 Resolution Chemicals Ltd Particle-size reduction apparatus, and the use thereof
TW200700079A (en) 2005-03-23 2007-01-01 Glaxosmithkline Biolog Sa Composition
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
EP1951200A2 (en) * 2005-08-09 2008-08-06 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
DK1945271T3 (da) 2005-10-24 2020-01-13 Magsense Life Sciences Inc Fremgangsmåde til fremstilling af polymerbelagte mikropartikler
KR101211386B1 (ko) * 2005-11-04 2012-12-13 노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. 알루미늄 보조제에 즉석 흡착되는 인플루엔자 백신
US20090304742A1 (en) 2005-11-04 2009-12-10 Novartis Vaccines And Diagnostics Srl Influenza vaccines with reduced amount of emulsion adjuvant
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
WO2007098186A2 (en) * 2006-02-22 2007-08-30 Novavax, Inc. Adjuvant and vaccine compositions
EP1849452A1 (de) * 2006-04-27 2007-10-31 Cognis IP Management GmbH Dispersionen, enthaltend Acylglutamate
EP2422810B1 (en) 2006-07-17 2014-10-22 GlaxoSmithKline Biologicals s.a. Influenza vaccine
GB0622282D0 (en) 2006-11-08 2006-12-20 Novartis Ag Quality control methods
CN101553252A (zh) 2006-12-06 2009-10-07 诺华有限公司 包含来自于四株流感病毒的抗原的疫苗
US8506966B2 (en) 2008-02-22 2013-08-13 Novartis Ag Adjuvanted influenza vaccines for pediatric use
CN102046011A (zh) 2008-04-04 2011-05-04 罗伯特·绍尔 微管相互作用剂的脂质-油-水纳米乳递送系统
US8187554B2 (en) 2008-04-23 2012-05-29 Microfluidics International Corporation Apparatus and methods for nanoparticle generation and process intensification of transport and reaction systems
WO2009155401A1 (en) 2008-06-19 2009-12-23 Neurosystec Corporation Formulations
NZ600254A (en) 2009-12-03 2013-10-25 Novartis Ag Arranging interaction and back pressure chambers for microfluidization
CL2012001399A1 (es) * 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
EP2506832B1 (en) 2009-12-03 2014-02-26 Novartis AG Hydrophilic filtration during manufacture of vaccine adjuvants
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506834B1 (en) 2009-12-03 2016-03-02 Novartis AG Circulation of components during homogenization and microfluidization of emulsions
DE102009056883B4 (de) * 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056871A1 (de) 2009-12-03 2011-06-22 Novartis AG, 4056 Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
WO2011106565A1 (en) 2010-02-24 2011-09-01 Travers William A Methods and devices for controlling particle size and particle size distribution
GB201009671D0 (en) 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process

Also Published As

Publication number Publication date
EP2506834A2 (en) 2012-10-10
DK2638895T3 (da) 2024-06-17
EA024770B1 (ru) 2016-10-31
US20200268661A1 (en) 2020-08-27
JP2015193656A (ja) 2015-11-05
US20180055769A1 (en) 2018-03-01
ES2573710T3 (es) 2016-06-09
SMT201300044B (it) 2013-07-09
EP2638895A2 (en) 2013-09-18
US8895629B2 (en) 2014-11-25
HUE066873T2 (hu) 2024-09-28
KR101523215B1 (ko) 2015-05-27
SI2506834T1 (sl) 2016-04-29
USRE46441E1 (en) 2017-06-20
NZ600323A (en) 2013-12-20
BR112012013427B8 (pt) 2021-05-25
BR112012013427B1 (pt) 2021-03-30
RS52748B (sr) 2013-08-30
CA2782511A1 (en) 2011-06-09
EP4410306A3 (en) 2024-11-13
CN102753149A (zh) 2012-10-24
HK1175404A1 (zh) 2013-07-05
SG10201501611QA (en) 2015-04-29
PT2356983E (pt) 2013-04-23
EA201290426A1 (ru) 2012-11-30
DK2356983T3 (da) 2013-03-11
MX344381B (es) 2016-12-14
JP5820390B2 (ja) 2015-11-24
EP2356983B1 (en) 2013-02-20
US11141376B2 (en) 2021-10-12
BR112012013427A2 (pt) 2016-04-05
MX2012006216A (es) 2012-07-12
SI2356983T1 (sl) 2013-05-31
WO2011067673A3 (en) 2012-05-10
CA2782511C (en) 2013-11-12
HK1160396A1 (en) 2012-08-17
KR20120099750A (ko) 2012-09-11
AU2010325752A1 (en) 2012-06-21
EP2638895B1 (en) 2024-03-20
US20160128937A1 (en) 2016-05-12
US9750690B2 (en) 2017-09-05
EP2506834B1 (en) 2016-03-02
CN102753149B (zh) 2015-10-14
JP2013512892A (ja) 2013-04-18
EP2638895A3 (en) 2014-02-19
IL219984A0 (en) 2012-07-31
FI2638895T3 (fi) 2024-06-20
US20130142833A1 (en) 2013-06-06
US10463615B2 (en) 2019-11-05
HRP20130398T1 (en) 2013-06-30
SG181096A1 (en) 2012-07-30
WO2011067673A2 (en) 2011-06-09
AU2010325752B2 (en) 2013-12-19
IL219984B (en) 2018-06-28
PL2356983T3 (pl) 2013-08-30
ES2975170T3 (es) 2024-07-03
ES2402569T3 (es) 2013-05-06
US20160113870A1 (en) 2016-04-28
EP4410306A2 (en) 2024-08-07
CN105055311A (zh) 2015-11-18
EP2356983A1 (en) 2011-08-17

Similar Documents

Publication Publication Date Title
MX2012006216A (es) Circulacion de componentes durante la homogenizacion de emulsiones.
EP2786714A3 (en) System for operating a surgical instrument
EP2634711A3 (en) System and method for structural analysis
EP4235548A3 (en) Method and apparatus for providing calendar displaying work history of document
WO2015030973A3 (en) Method and system for generating a composite ultrasound image
MX2013005921A (es) Metodo y aparato para registro ocular multi-nivel.
IL277011B (en) Hybrid elastographic method, probe and device for hybrid elastography
GB2534034B (en) Ultrasonic measuring system, means of transportation and method for operating an ultrasonic transmitter-receiver device
EP2763376A3 (en) Method and device for providing service
BR112016020987A8 (pt) método de identificação de receptores de aloenxerto renal, kit, conjunto de assinatura gênica, método de seleção de paciente e uso de um agente imunossupressivo
GB2547056B (en) A system for determining the condition of a fluid in a tank, an apparatus including the system and a method for managing the condition of the fluid
SG10201805841PA (en) Method and device for producing an electronic signed document
GB201103780D0 (en) Treatment for ige-mediated disease
IL264759B1 (en) A stitch release device for sewing embroidery
SG11202104236UA (en) System, method, and apparatus for generating tokenized images
KR102249528B9 (ko) 미리 저장된 그라데이션 데이터 및 영상을 이용하여 초음파 영상의 밝기를 조정하는 방법, 장치 및 시스템.
EP3526686A4 (en) METHOD AND SYSTEM FOR A DISTRIBUTION AND DISTRIBUTION PLATFORM OF ELECTRONIC STRUCTURED CONTENT
PH12016502072A1 (en) Program output apparatus, program management server, assistance information management server, method for outputting program and assistance information, and storage medium
EP3093948A3 (en) Voltage regulation in wireless power receiver
GB201516608D0 (en) Ultrasonic measuring system, ultrasonic scanner and method for investigating an ultrasonic echo
MX2009007932A (es) Metodo y aparato para manejar especificaciones de sistema.
EP2674923A3 (en) Item validation
EP3102112A4 (en) Method, apparatus, and system for generating diagnostic image using photoacoustic material
EP2613261A3 (en) Environment construction apparatus and method, environment registration apparatus and method, environment switching apparatus and method
CY1113946T1 (el) Κυκλοφορια συστατικων κατα τη διαρκεια ομογενοποιησης γαλακτωματων